Neogenomics Inc

Change company Symbol lookup

Select an option...

NEO Neogenomics Inc

FOSL Fossil Group Inc

AON Aon PLC

RIINF Canadian Critical Minerals Inc

BB BlackBerry Ltd

PXD Pioneer Natural Resources Co

SIEN Sientra Inc

NVDA NVIDIA Corp

MTTR Matterport Inc

CHPT ChargePoint Holdings Inc

Go

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories. The Company operates through two segments: the Clinical Services Segment and the Pharma Services Segment. The Clinical Services segment provides various clinical testing services to community-based pathology practices, oncology practices, hospital pathology labs, reference labs, and academic centers with reimbursement from various payers, including client direct billing, commercial insurance, Medicare and other government payers, and patients. The Pharma Services segment supports pharmaceutical firms in their drug development programs by providing testing services and data analytics for clinical trials and research. The Company offers testing services, which include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, immunohistochemistry (IHC) and digital imaging, molecular testing and morphologic analysis. It operates testing laboratories in United States, Europe and Asia.